Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans

Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.410
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search